Press release
Asia Pacific and Middle East to lead Epidermal Growth Factor Receptor (EGFR) Antibodies Market by 2015-2021
Get a copy of free Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=67199
On the basis of types, the global epidermal growth factor receptor (EGFR) antibodies market is segmented into cetuximab, panitumumab, and nimotuzumab. Cetuximab and panitumumab are the most favored EGFR antibodies which are utilized for treatment of cancer. Nimotuzumab is a humanized monoclonal antibody that recognizes the EGFR antibody. These antibodies are used in the treatment of colorectal tumor as single chairmen and in mix with routine chemotherapy.
The report covers forecast and analysis for the epidermal growth factor receptor (EGFR) antibodies market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). The report also offers detailed competitive landscape of the global epidermal growth factor receptor (EGFR) antibodies market. It includes company market share analysis, product portfolio of the major industry participants. The report provides detailed segmentation of the epidermal growth factor receptor (EGFR) antibodies market based on type segment. Cetuximab, panitumumab, and nimotuzumab are different type of EGFR antibodies.
Get in-depth TOC (Table of Contents) with Tables and Figures @ https://goo.gl/OvhyYT
Increasing rate of cancer around the world, and advancement in the treatments are few drivers for EGFR antibody market. Prevalence of cancer is high in North America specifically in U.S. Cancer cases globally are escalating at an alarming rate. Cancer represents a key challenge to development, undermining economic and social advances all over the world. Breast cancer is most common diagnosed cancer and second leading cause of death amongst women in the U.S. According to World Cancer Report, produced by the WHO's specialized cancer agency, predicted that new cancer cases would rise from 14 million annually in 2012 to 22 million within two decades.
Geographically, epidermal growth factor receptor (EGFR) antibodies market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. EGFR antibody market was dominated by North America followed by Europe. Key players in this market are Biocon ltd, Bristol-Myers Squibb, Vaccinex, NovelMed Therapeutics, Janssen Biotech (J&J), Merck, Angiochem , Bio-Synthesis, Antibody Systems
Inquire more before buying this report @ https://goo.gl/NVzWVz
Epidermal Growth Factor Receptor (EGFR) Antibodies Market: Type Segment Analysis
Cetuximab
Panitumumab
Nimotuzumab
Epidermal Growth Factor Receptor (EGFR) Antibodies Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East & Africa
Browse detail report @ http://www.syndicatemarketresearch.com/market-analysis/epidermal-growth-factor-receptor-egfr-antibodies-market-global.html
About Us:
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Syndicate Market Research cover more than 30 industries including energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with the one-stop solution for all the research requirements.
Contact Us:
Joel John
3422 SW 15 Street, Suite #8138
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific and Middle East to lead Epidermal Growth Factor Receptor (EGFR) Antibodies Market by 2015-2021 here
News-ID: 402774 • Views: …
More Releases from SMR
Mobile Robotics Market– Global Industry Perspective, Comprehensive Analysis an …
Mobile robotics is programmable manipulator able to perform multipurpose activities as human within an environment. Mobile robotics is designed on hardware platforms with suitable software tools. Mobile robot operates in a different environment and connects to different sensors and actuators. Mobile robots are form of locomotion mechanism enables the robot to act on environment. Mobile robotics technology is becoming popular in various sectors such agricultural, medical and defense. Farmers use…
Double-Digit Growth Rates for VoIP Services Market
VoIP stands for Voice over Internet Protocol. VoIP is a service that manipulates assorted data and voice transmission technologies to provide communication services over a packet-switched network. The technologies used in VoIP Service include IP telephony, voice over broadband and Internet telephony. This service support digital signals for transmitting data over IP-based network. VoIP services are executed by means of a broad range of protocols such as H.323,…
Market Opportunities Aplenty as Adoption of "Aerial Imaging Market" Grows
Aerial imaging involves capturing images or pictures of the ground from an eminent point through camera. While capturing the images the camera is not ground based supported, it is at particular height may attached to any helicopters, parachutes, fixed-wing aircraft, dirigibles and blimps, kites, multi-rotor unmanned aircraft systems (UAS), balloons, rockets, vehicle-mounted poles. The aerial imaging provides competent elucidation for various intentions like route design, planning, volume calculation map…
Modest Growth Forecast for Global Human Machine Interface Market
Human Machine Interface (HMI) is control system which provides a graphics-based visualization of an industrial managing and monitoring system. Human machine interface also referred as operator panel and user interface. Human machine interface typically located on the portable handheld devices and also in centralized control rooms. Human machine interface plays a vital role in the automotive industry. The human machine interface comprises electronics required to control the state of…
More Releases for EGFR
EGFR Inhibitors Market to Reach USD 16 Billion by 2034
Targeting Lung Cancer with Precision: EGFR Inhibitors Market to Reach USD 16 Billion by 2034
The global burden of non-small cell lung cancer (NSCLC), the most prevalent form of lung cancer, continues to rise, and so does the demand for more targeted, effective, and personalized treatments. Epidermal Growth Factor Receptor (EGFR) inhibitors have emerged as a game-changing class of targeted therapies that address EGFR gene mutations-common drivers in NSCLC patients, especially…
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Market Growth 2025: Trends, Consu …
The EGFR non-small cell lung cancer (EGFR + NSCLC) market is estimated to be valued at USD 4.65 Bn in 2025 and is expected to reach USD 7.92 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.
The Latest published market study on EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Market report provides an overview of the current market dynamics as well…
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Clinical Trials 2024: EMA, PDMA, …
(New York, United States) As per DelveInsight's assessment, globally, EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline constitutes 30+ key companies continuously working towards developing 30+ EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the…
EGFR Non-Small Cell Lung Cancer Pipeline Report 2024
DelveInsight's, "EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insights 2024" report provides comprehensive insights about 40+ EGFR Non-Small Cell Lung Cancer companies and 42+ pipeline drugs in the EGFR Non-Small Cell Lung Cancer pipeline landscape. It covers the EGFR Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the EGFR Non-Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage,…
EGFR Mutation Test Market to Show Incredible Growth by 2027 | Novartis, Illumina
It shows how the COVID-19 health problem has affected a variety of companies. The COVID-19 epidemic and related lockdown countermeasures have wreaked havoc on several various segments of the economy; however, a few have seen growing demands. This EGFR Mutation Test market report's major objective is to forecast market growth from 2021 to 2027. A Market Report is the result of a data-driven strategy. It displays data in a visually…
EGFR Mutation Test Market Estimated to Flourish by 2016 – 2024
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are…
